GALLETTI, SERENA
GALLETTI, SERENA
Dipartimento di Oncologia ed Emato-Oncologia
Expanding the repertoire of miRNAs and miRNA-offset RNAs expressed in multiple myeloma by small RNA deep sequencing
2019 L. Agnelli, A. Bisognin, K. Todoerti, M. Manzoni, E. Taiana, S. Galletti, G. Cutrona, E. Gaffo, S. Bortoluzzi, A. Neri
THE ROLE OF NOTCH PATHWAY IN MULTIPLE MYELOMA PROGRESSION: CONTROL OF IL-6 EXPRESSION IN MALIGNANT PLASMA CELLS AND BONE MARROW NICHE
2017 S. Galletti
Jagged-directed therapy in multiple myeloma: a new approach to interrupt the crosstalk between the tumor cell and the bone marrow microenvironment
2017 M. Colombo, S. Galletti, S. Garavelli, R. Colella, F. Baccianti, N. Platonova, M. Palano, E. Lazzari, K. Thümmler, K. Todoerti, L.A. Crews, C.H.M. Jamieson, C. Goodyear, A. Neri, R. Chiaramonte
Rational for molecular targeting the communication of multiple myeloma and bone marrow niche : why Notch?
2017 M. Colombo, F. Baccianti, L. Cantone, A. Moschini, N. Platonova, S. Garavelli, S. Galletti, V. Bollati, C. Goodyear, A. Neri, R. Chiaramonte
The role of notch pathway in multiple myeloma associated drug resistance
2017 S. Garavelli, E. Lazzari, M. Colombo, N. Platonova, M.T. Palano, F. Baccianti, S. Galletti, A. Neri, L..A. Crews, C.H. Jamieson, R. Chiaramonte
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance
2016 S. Garavelli, E. Lazzari, M. Colombo, M.T. Palano, F. Baccianti, F. Farris, N. Platonova, S. Galletti, K. Todoerti, A.L. Crews, H.M..C. Jamieson, A. Neri, R. Chiaramonte
Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche
2016 M. Colombo, S. Galletti, G. Bulfamante, M. Falleni, D. Tosi, K. Todoerti, E. Lazzari, L.A. Crews, C.H.M. Jamieson, S. Ravaioli, F. Baccianti, S. Garavelli, N. Platonova, A. Neri, R. Chiaramonte
lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome
2016 D. Ronchetti, M. Manzoni, L. Agnelli, C. Vinci, S. Fabris, G. Cutrona, S. Matis, M. Colombo, S. Galletti, E. Taiana, A.G. Recchia, S. Bossio, M. Gentile, C. Musolino, F. Di Raimondo, A. Grilli, S. Bicciato, A. Cortelezzi, P. Tassone, F. Morabito, M. Ferrarini, A. Neri
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma
2016 D. Ronchetti, L. Agnelli, E. Taiana, S. Galletti, M. Manzoni, K. Todoerti, P. Musto, F. Strozzi, A. Neri
Notch pathway and Inteleukin-6 cooperate to support multiple myeloma cell proliferation
2015 S. Galletti, M. Colombo, S. Ravaioli, S. Garavelli, G. Bulfamante, M. Falleni, D. Tosi, A. Moschini, A. Paoli, K. Todoerti, A. Neri, R. Chiaramonte
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance
2015 S. Garavelli, E. Lazzari, M. Colombo, A. Paoli, A. Moschini, N. Platonova, S. Galletti, K. Todoerti, A.L. Crews, H.M..C. Jamieson, A. Neri, R. Chiaramonte
Understanding the interaction of human cancer cells with the surrounding microenvironment: the new challenge in modern oncology
2015 M. Colombo, S. Garavelli, K. Thümmler, E. Lazzari, K. Todoerti, A. Moschini, L. Cantone, S. Galletti, N. Platonova, A. Paoli, G. Bulfamante, M. Falleni, D. Tosi, V. Bollati, L.A. Crews, C.S. Goodyear, C.H. Jamieson, A. Neri, R. Chiaramonte
Notch pathway and Interleukin-6 cooperate and support multiple myeloma cell growth
2015 S. Galletti, M. Colombo, S. Ravaioli, S. Garavelli, K. Todoerti, N. Platonova, A. Neri, R. Chiaramonte
The notch ligands Jagged1 and 2 are a potential therapeutic target in multiple myeloma- associated bone disease
2015 M. Colombo, S. Garavelli, K. Todoerti, A. Paoli, N. Platonova, S. Galletti, A. Neri, R. Chiaramonte
Bone marrow-mediated drug resistance is promoted by Jagged-induced notch pathway in multiple myeloma
2015 S. Garavelli, E. Lazzari, M. Colombo, A. Paoli, N. Platonova, S. Galletti, K. Todoerti, A. Neri, R. Chiaramonte
Notch signaling deregulation in multiple myeloma : a rational molecular target
2015 M. Colombo, S. Galletti, S. Garavelli, N. Platonova, A. Paoli, A. Basile, E. Taiana, A. Neri, R. Chiaramonte
Multiple myeloma-associated drug resistance : targeting the Notch pathway
2015 S. Garavelli, E. Lazzari, M. Colombo, A. Paoli, A. Moschini, N. Platonova, S. Galletti, K. Todoerti, A. Neri, R. Chiaramonte
AKT regulation of oncogenic Notch pathway in T-cell acute lymphoblastic leukemia
2015 N. Platonova, E. Vigolo, G. Cermisoni, D. De Simone, M. Colombo, S. Garavelli, E. Lazzari, S. Galletti, A. Paoli, A. Neri, R. Chiaramonte
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias : implication for MEK-ERK pathway activation
2015 M. Lionetti, M. Barbieri, K. Todoerti, L. Agnelli, S. Marzorati, S. Fabris, G. Ciceri, S. Galletti, G. Milesi, M. Manzoni, M. Mazzoni, A. Greco, G. Tonon, P. Musto, L. Baldini, A. Neri
Bone marrow-mediated drug resistance is promoted by Jagged-induced Notch signaling in multiple myeloma
2014 S. Garavelli, E. Lazzari, M. Colombo, S. Ravaioli, N. Platonova, M. Lancellotti, L. Apicella, L. Mirandola, S. Galletti, K. Todoerti, A. Neri, R. Chiaramonte